Developer of pharmaceuticals products. The company develops needle-free, non-inhaled insulin delivery technology which involves suspension of macro-molecular drugs, such as insulin to facilitate systemic delivery via the buccal membrane.
What you see here scratches the surface
We’ll help you find what you need
This information is available in the PitchBook Platform. To explore Vectoris Pharma‘s full profile, request access.
© 2021 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.